Asymchem's Dunhua 2 Carbapenem Manufacturing Site Successfully Completes its First FDA Inspection for Continuous Manufacturing of an API

TIANJIN, China, July 24, 2026 /PRNewswire/ -- Asymchem, a leading global contract development and manufacturing organization (CDMO), announced that its dedicated carbapenem API manufacturing facility (Jilin Asymchem Pharmaceuticals Co. Ltd., also known as "DH2") successfully completed its...